Goa as a Micro-Gateway to India’s Sunrise Sectors: Beyond the India-UK CETA Headlines

When India and the United Kingdom (UK) signed the Comprehensive Economic and Trade Agreement (CETA)—flanked by the ambitious India-UK Vision 2035—the official declarations were full of the usual diplomatic shorthand: bilateral trade targets, tariff line cuts, and strategic alignment. Yet, beyond the predictable talking points lies a trade pact that fundamentally redefines India’s standing on the global stage.

As India’s most comprehensive trade agreement with a G-7 economy and the UK’s most significant trade deal since leaving the European Union, CETA is not merely about exchanging commodities—it is a blueprint built on what both nations term “BRISK” (Business, Research, Innovation, Science and Technology, and Knowledge).

While headlines have focused on immediate win-wins like the 5-year social security exemption for over 75,000 Indian professionals under the companion Double Contribution Convention, a deeper look reveals three quiet, structural revolutions hidden within the fine print.

Goa is poised to unlock new export opportunities under the India–UK CETA.

Redefining IP Sovereignty

For decades, international trade negotiations saw India taking a defensive stance on Intellectual Property Rights (IPR), fiercely guarding its generic drug industry against Western pharmaceutical giants. CETA turns that dynamic on its head. Far from compromising India's sovereignty, the agreement’s IP chapter reflects the sure-footed confidence of an emerging global innovation hub.

Crucially, while CETA establishes voluntary licensing as the preferred path for technology transfer and access to medicines, it explicitly safeguards India's full rights under the WTO TRIPS agreement—including the right to grant compulsory licenses during national health emergencies.

Rather than diluting India's leadership of the Global South, the framework creates a stable environment for deep R&D collaboration while keeping public health flexibilities completely intact.

"The objective of the chapter is that the protection and enforcement of IPRs should contribute to the promotion of technological innovation and technology transfer... reaffirming the full right to use all the flexibilities available for putting in place public health measures." 

— Section A, Intellectual Property Rights Chapter, India-UK CETA.

The data underscores why this pivot matters. India, as the pharmacy to the world, already supplies 25% of all medicines used in the UK. Further, India hosts over 100 healthcare Global Capability Centres (GCCs), employing roughly 40% of the world's healthcare GCC workforce in advanced diagnostics and AI-driven drug discovery. To drive technological innovation, Indian patent filings have registered double-digit growth for six consecutive years, with 15% originating in MedTech and pharma.

By securing immediate zero-duty access for Indian generic exports (eliminating previous UK tariffs of up to 8%), CETA allows Indian pharma to transition from being a low-cost manufacturer to an indispensable co-innovator in Europe’s gateway market.

Defence and Aerospace

Between 2019 and 2023, the UK accounted for less than 4% of India’s defence imports, significantly behind Russia (36%), France (33%) and the US (13%). Building on the foundation of CETA, the recently published 10-year Roadmap for India-UK Defence Industrial Cooperation – under the Vision 2035 – abruptly shifts this relationship from transactional procurement to joint strategic sovereignty and extensive defence capability collaboration and interoperability across multiple domains, through co-design, co-development, and co-production. The plan, by 2035, is to integrate both countries industrial bases and defence manufacturing supply chains.

Instead of off-the-shelf purchases, the UK and India will focus on niche, high-value technologies that directly bolster India's Atmanirbhar Bharat (Self-Reliant India) ambitions:

(a) through the Jet Engine Advanced Core Technologies (JEACT) initiative, Rolls-Royce has offered joint co-production with complete technology sharing, helping power India's next-generation Advanced Medium Combat Aircraft (AMCA) (b) a Statement of Intent under the Electric Propulsion Capability Partnership (EPCP) introduces Integrated Full Electric Propulsion (IFEP) featuring Rolls-Royce MT-30 gas turbines for the Indian Navy's future warships and Landing Platform Docks (LPDs)—delivering stealth, fuel efficiency, and energy capacity for directed-energy weapons

(c) facilities like the MBDA UK and Bharat Dynamics Limited (BDL) plant in Hyderabad for Advanced Short-Range Air-to-Air Missiles (ASRAAM) position India not just as an end-user, but as an active exporter in global defence supply chains.

Goa as a Micro-Gateway to India’s Sunrise Sectors

Perhaps the most unexpected takeaway from CETA is how its macro-level tariff reductions act as a powerful catalyst for smaller, export-focused coastal states—with Goa serving as a prime case study. Goa demonstrates that CETA’s true economic impact will not be measured solely in Delhi or Mumbai, but in how regional hubs leverage specialized market access.

While not a heavy manufacturing hub, Goa punches well above its weight in three sunrise sectors directly targeted by CETA’s tariff cuts.

First, producing over ₹6,527 crore in pharmaceutical exports annually (5.6% of India's total), Goa’s pharma cluster gains immediate zero-duty access to the UK, driving investments in high-value formulations.

Second, with over 45,000 tonnes of annual fish landings (primarily mackerel and squid), Goan exporters previously depended heavily on Southeast Asian markets. The complete elimination of the UK's 21.5% marine tariff gives Goan processors a direct incentive to meet UK sanitary standards and capture premium European market share.

Third, as India reduces import duties on Scotch whisky from 150% to 75% in year one, reciprocal tariff easing in the UK opens a unique window for Goan craft distillers and Geographical Indication (GI)-tagged spirits like heritage Feni to market themselves to British consumers.

Trade agreements rarely transform economies overnight; they create access, not guaranteed outcomes. The UK’s long-term projection estimates CETA will add £4.8 billion (0.13%) to UK GDP, reminding us that an FTA is a framework, not a finish line. For Indian businesses, capitalizing on CETA will require rigorous investment in compliance, international quality certifications, and supply chain logistics. Yet, CETA represents something far bigger than immediate balance-of-trade figures. It marks India’s transition into a confident global negotiator—one capable of safeguarding its national interests while co-authoring the rules of 21st-century technology, defence, and trade.

This article is written by:-

Professor Ashish Bharadwaj

Pro Vice Chancellor of WPU Goa

Mr. Richard McCallum

Senior Advisor, UK India Business Council

Disclaimer

The views and opinions expressed in this article are those of the contributors and do not necessarily reflect the official policy, position, or editorial stance of EIJ. EIJ provides a platform for diverse perspectives and informed debate. Responsibility for the accuracy of facts and interpretations rests solely with the authors.